ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

37
Analysis
Health CareJapan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Refresh
bullishSanBio Co Ltd
14 Jun 2024 10:00Issuer-paid

SanBio Co Ltd (4592 JP): Q1 FY01/25 flash update

The company reported no operating revenue and an operating loss of JPY667mn in Q1 FY01/25, down from JPY1.5bn. Non-operating income was JPY768mn,...

Logo
164 Views
Share
bullishSanBio Co Ltd
14 Jun 2024 04:12Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/24 flash update

SanBio reported no operating revenue in FY01/24, with an operating loss of JPY4.5bn and recurring loss of JPY2.8bn. The company issued 9 million...

Logo
114 Views
Share
bullishSanBio Co Ltd
14 Jun 2024 04:04Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/24 flash update

FY01/24 operating loss narrowed to JPY4.5bn from JPY8.0bn in FY01/23; net loss reduced to JPY2.6bn from JPY5.6bn. SanBio issued 9mn new shares in...

Logo
10 Views
Share
bullishSanBio Co Ltd
14 Jun 2024 03:48Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/24 flash update

FY01/24: Operating revenue was none, operating loss narrowed to JPY4.5bn, recurring loss was JPY2.8bn, net loss was JPY2.6bn. FY01/25 forecast: No...

Logo
9 Views
Share
bullishSanBio Co Ltd
14 Jun 2024 03:31Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/24 flash update

In FY01/24, SanBio reported no operating revenue, an operating loss of JPY4.5bn, and a net loss of JPY2.6bn. SanBio issued 9 million new shares in...

Logo
2 Views
Share
x